InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-37.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Rajangam Kanya, Directeur Médical. Officer active across 2 companies, notably Nkarta, Inc.. In total, 8 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €5k. Activity tracked since 5 August 2021. The latest transaction was disclosed on 10 March 2025 (C). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
33,000 shares@ US$2.2593.0% of flowCommon StockSEC:0001854270-25-000034:0
78,363 shares0Common StockSEC:0001854270-25-000015:0
1,297 shares@ US$4.077.0% of flowCommon StockSEC:0001854270-25-000002:0
101,000 shares0Common StockSEC:0001854270-24-000017:0
12,800 shares0Common StockSEC:0001209191-22-003756:0
12,800 shares0Common StockSEC:0001209191-22-003756
10,000 shares@ US$0.410.0018% mcap50.0% of flowCommon StockSEC:0000899243-21-032196:0
10,000 shares@ US$0.4150.0% of flowCommon StockSEC:0000899243-21-032196
8 of 8 declarations
About Rajangam Kanya
Kanya Rajangam is the Chief Medical Officer at Nkarta, Inc. She is responsible for leading the company's medical and clinical initiatives. With deep expertise in the medical field, she plays a key role in developing innovative treatments and overseeing clinical trials.
